- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
KRT13 Antibody rKRT13/9623 recognizes keratin 13, a type I intermediate filament protein encoded by the KRT13 gene on chromosome 17. Cytokeratin 13 is primarily expressed in nonkeratinized stratified squamous epithelia, including the oral mucosa, esophagus, cervix, and other mucosal surfaces. Its expression is associated with epithelial differentiation, particularly in suprabasal cells that have progressed beyond the proliferative basal compartment. The protein contributes to cytoskeletal organization and helps epithelial cells withstand mechanical stress. Because its distribution varies with epithelial maturation and tissue specialization, keratin 13 is frequently examined in studies of mucosal development, squamous epithelial differentiation, and disease-associated changes in tissue architecture.
Keratin 13 typically forms heterodimers with keratin 4, a type II intermediate filament protein expressed in many of the same epithelial tissues. These keratin pairs assemble into filament networks that provide structural support and contribute to epithelial integrity. Their expression distinguishes nonkeratinized mucosal epithelia from keratinized epidermis, where keratins 1 and 10 are prominent. Basal epithelial cells generally express keratins 5 and 14, while differentiated suprabasal cells acquire keratin profiles suited to their specialized functions. Examining CK13 alongside these markers helps researchers characterize epithelial stratification and identify changes in cellular differentiation.
Altered KRT13 expression has been documented in squamous epithelial dysplasia and carcinomas, particularly in the oral cavity and esophagus. Reduced or heterogeneous expression may accompany malignant transformation and changes in epithelial differentiation, although staining patterns depend on tumor origin and histological characteristics. Inherited pathogenic variants in KRT13 are associated with white sponge nevus, a benign disorder characterized by thickened white plaques of the oral mucosa. Investigations involving keratin 13 therefore contribute to understanding epithelial barrier function, inherited keratin disorders, and the molecular changes associated with squamous neoplasia.
NSJ Bioreagents offers recombinant mouse monoclonal clone rKRT13/9623 for investigating human keratin 13 expression. Developed using esophageal keratins of rabbit origin as the immunogen, this antibody is validated for immunohistochemistry on formalin-fixed, paraffin-embedded tissues. Its recombinant monoclonal format provides a defined antibody reagent for examining cytoplasmic keratin expression in epithelial specimens. The Keratin 13 Monoclonal Antibody offers an additional clone option for investigating mucosal epithelial differentiation and tissue-associated cytokeratin patterns. A KRT13 Antibody such as rKRT13/9623 supports research into epithelial organization, squamous tissue pathology, and keratin-associated disease.
Explore our Cytokeratin 13 Antibody KRT13/2659 for investigating keratin 13 expression, nonkeratinized squamous epithelial differentiation, and changes in cytokeratin distribution associated with epithelial disease.
Optimal dilution of the KRT13 Antibody rKRT13/9623 / Keratin 13 Monoclonal Antibody should be determined by the researcher.
Esophageal keratins of rabbit origin were used as the immunogen for the KRT13 Antibody rKRT13/9623.
Aliquot the KRT13 Antibody rKRT13/9623 and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Cytokeratin 13 antibody, CK13 antibody, Keratin 13 antibody, Cytokeratin-13 antibody, Keratin-13 antibody, Type I Cytoskeletal Keratin 13 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.